Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
September 30, 2026 -12.59M
June 30, 2026 -9.606M
March 31, 2026 -15.07M
December 31, 2025 -14.60M
September 30, 2025 -6.722M
June 30, 2025 -6.402M
March 31, 2025 -18.07M
December 31, 2024 -8.800M
September 30, 2024 -16.66M
June 30, 2024 -13.26M
March 31, 2024 -13.04M
December 31, 2023 -10.25M
September 30, 2023 -11.63M
June 30, 2023 -13.27M
March 31, 2023 -16.51M
December 31, 2022 -35.88M
September 30, 2022 -26.86M
June 30, 2022 -21.63M
March 31, 2022 -19.43M
December 31, 2021 -37.66M
September 30, 2021 -20.92M
June 30, 2021 -17.21M
March 31, 2021 -16.09M
December 31, 2020 -6.929M
September 30, 2020 -12.50M
Date Value
June 30, 2020 -4.954M
March 31, 2020 -3.425M
June 30, 2019 -3.667M
March 31, 2019 -2.012M
December 31, 2018 -3.148M
September 30, 2018 -1.671M
June 30, 2018 -2.266M
March 31, 2018 -1.625M
December 31, 2017 -1.132M
September 30, 2017 -0.979M
June 30, 2017 -1.016M
March 31, 2017 -1.855M
December 31, 2016 -1.450M
September 30, 2016 -2.144M
June 30, 2016 -2.826M
March 31, 2016 -3.627M
December 31, 2015 -3.475M
September 30, 2015 -3.216M
June 30, 2015 -4.489M
March 31, 2015 -4.432M
December 31, 2014 -4.984M
September 30, 2014 -2.322M
August 31, 2014
May 31, 2014
February 28, 2014 0.396M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Talphera, Inc. -3.034M
Journey Medical Corp. -3.437M
ANI Pharmaceuticals, Inc. 83.79M
Corcept Therapeutics, Inc. 142.89M
Veru, Inc. -5.467M